{"altmetric_id":3908276,"counts":{"readers":{"mendeley":64,"citeulike":0,"connotea":0},"total":{"posts_count":16},"twitter":{"unique_users_count":12,"unique_users":["AnestesiaF","Pro_antibiotic","AntibioticLeeds","MGilchrist123","mdialop1","jaime_latour","aky_synes","FarmUCI","AnesthRea","kadsho","jjcrazydiamond","matthewjrowland"],"posts_count":16}},"selected_quotes":["Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter RCT","Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized\u2026","PAPER 2: RCT of polymyxin B in 18 ICUs #LIVES2016","Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis"],"citation":{"abstract":"To test whether the polymyxin B hemoperfusion (PMX HP) fiber column reduces mortality and organ failure in peritonitis-induced septic shock (SS) from abdominal infections.\nProspective, multicenter, randomized controlled trial in 18 French intensive care units from October 2010 to March 2013, enrolling 243 patients with SS within 12\u00a0h after emergency surgery for peritonitis related to organ perforation. The PMX HP group received conventional therapy plus two sessions of PMX HP. Primary outcome was mortality on day 28; secondary outcomes were mortality on day 90 and a reduction in the severity of organ failures based on Sequential Organ Failure Assessment (SOFA) scores.\nPrimary outcome: day 28 mortality in the PMX HP group (n\u00a0=\u00a0119) was 27.7 versus 19.5\u00a0% in the conventional group (n\u00a0=\u00a0113), p\u00a0=\u00a00.14 (OR 1.5872, 95\u00a0% CI 0.8583-2.935). Secondary endpoints: mortality rate at day 90 was 33.6\u00a0% in PMX-HP versus 24\u00a0% in conventional groups, p\u00a0=\u00a00.10 (OR 1.6128, 95\u00a0% CI 0.9067-2.8685); reduction in SOFA score from day 0 to day 7 was -5 (-11 to 6) in PMX-HP versus -5 (-11 to 9), p\u00a0=\u00a00.78. Comparable results were observed in the predefined subgroups (presence of comorbidity; adequacy of surgery,\u00a0<2 sessions of hemoperfusion) and for SOFA reduction from day 0 to day 3.\nThis multicenter randomized controlled study demonstrated a non-significant increase in mortality and no improvement in organ failure with PMX HP treatment compared to conventional treatment of peritonitis-induced SS.","altmetric_jid":"4f6fa4ed3cf058f610002af6","authors":["Didier M. Payen","Joelle Guilhot","Yoann Launey","Anne Claire Lukaszewicz","Mahmoud Kaaki","Benoit Veber","Julien Pottecher","Olivier Joannes-Boyau","Laurent Martin-Lefevre","Matthieu Jabaudon","Olivier Mimoz","R\u00e9mi Coudroy","Martine Ferrandi\u00e8re","Eric Kipnis","Carlos Vela","St\u00e9phanie Chevallier","Jihad Mallat","Ren\u00e9 Robert","The ABDOMIX Group","Payen, Didier M","Guilhot, Joelle","Launey, Yoann","Lukaszewicz, Anne Claire","Kaaki, Mahmoud","Veber, Benoit","Pottecher, Julien","Joannes-Boyau, Olivier","Martin-Lefevre, Laurent","Jabaudon, Matthieu","Mimoz, Olivier","Coudroy, R\u00e9mi","Ferrandi\u00e8re, Martine","Kipnis, Eric","Vela, Carlos","Chevallier, St\u00e9phanie","Mallat, Jihad","Robert, Ren\u00e9",", "],"doi":"10.1007\/s00134-015-3751-z","endpage":"984","first_seen_on":"2015-04-14T21:57:05+00:00","funders":["niehs"],"issns":["1432-1238","0342-4642"],"issue":"6","journal":"Intensive Care Medicine","last_mentioned_on":1475566180,"links":["http:\/\/link.springer.com\/article\/10.1007\/s00134-015-3751-z","http:\/\/www.researchgate.net\/publication\/274782025_Early_use_of_polymyxin_B_hemoperfusion_in_patients_with_septic_shock_due_to_peritonitis_a_multicenter_randomized_control_trial","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25862039?dopt=Abstract","http:\/\/link.springer.com\/article\/10.1007%2Fs00134-015-3751-z","https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25862039"],"pdf_url":"http:\/\/link.springer.com\/content\/pdf\/10.1007%2Fs00134-015-3751-z.pdf","pmid":"25862039","pubdate":"2015-04-11T00:00:00+00:00","publisher":"Springer Berlin Heidelberg","publisher_subjects":[{"name":"Anesthesiology","scheme":"springer"},{"name":"Emergency Medicine","scheme":"springer"},{"name":"Intensive \/ Critical Care Medicine","scheme":"springer"},{"name":"Medicine & Public Health","scheme":"springer"},{"name":"Pain Medicine","scheme":"springer"},{"name":"Pediatrics","scheme":"springer"},{"name":"Pneumology\/Respiratory System","scheme":"springer"},{"name":"Clinical Sciences","scheme":"era"},{"name":"Public Health And Health Services","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"975","subjects":["criticalcare"],"title":"Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial","type":"article","volume":"41","mendeley_url":"http:\/\/www.mendeley.com\/research\/early-polymyxin-b-hemoperfusion-patients-septic-shock-due-peritonitis-multicenter-randomized-control-2"},"altmetric_score":{"score":6,"score_history":{"1y":0.25,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":6},"context_for_score":{"all":{"total_number_of_other_articles":7862537,"mean":6.658320282153,"rank":1241854,"this_scored_higher_than_pct":83,"this_scored_higher_than":6553751,"rank_type":"exact","sample_size":7862537,"percentile":83},"similar_age_3m":{"total_number_of_other_articles":201325,"mean":9.0870923685205,"rank":43322,"this_scored_higher_than_pct":78,"this_scored_higher_than":157738,"rank_type":"exact","sample_size":201325,"percentile":78},"this_journal":{"total_number_of_other_articles":2068,"mean":6.5875520077407,"rank":486,"this_scored_higher_than_pct":75,"this_scored_higher_than":1556,"rank_type":"exact","sample_size":2068,"percentile":75},"similar_age_this_journal_3m":{"total_number_of_other_articles":80,"mean":4.3196202531646,"rank":18,"this_scored_higher_than_pct":77,"this_scored_higher_than":62,"rank_type":"exact","sample_size":80,"percentile":77}}},"demographics":{"poster_types":{"member_of_the_public":11,"practitioner":1},"users":{"twitter":{"cohorts":{"Members of the public":11,"Practitioners (doctors, other healthcare professionals)":1}},"mendeley":{"by_status":{"Unspecified":2,"Professor > Associate Professor":4,"Researcher":17,"Student  > Doctoral Student":7,"Student  > Ph. D. Student":6,"Student  > Postgraduate":4,"Other":15,"Student  > Master":4,"Lecturer":2,"Professor":3},"by_discipline":{"Materials Science":1,"Medicine and Dentistry":59,"Agricultural and Biological Sciences":1,"Biochemistry, Genetics and Molecular Biology":1,"Unspecified":2}}},"geo":{"twitter":{"GB":3,"JP":3,"FR":1},"mendeley":{"JP":1,"BR":3,"IT":2,"FR":1,"RU":1}}},"posts":{"twitter":[{"url":"https:\/\/twitter.com\/AnestesiaF\/status\/587195649235488768","license":"datasift","citation_ids":[3908276],"posted_on":"2015-04-12T10:08:47+00:00","author":{"name":"Anestesia-Fabumed","url":"http:\/\/www.fabumed.net\/","image":"https:\/\/pbs.twimg.com\/profile_images\/513933046764957696\/2ZhExTfY_normal.png","description":"Anestesia. Compartir, revisar y fomentar la realizaci\u00f3n de referencias de la Literatura M\u00e9dica Latinoamericana y a sus Autores.","id_on_source":"AnestesiaF","tweeter_id":"380571588","geo":{"lt":null,"ln":null},"followers":1638},"tweet_id":"587195649235488768"},{"url":"https:\/\/twitter.com\/Pro_antibiotic\/status\/588098899790929921","license":"datasift","rt":["FarmUCI"],"citation_ids":[3908276],"posted_on":"2015-04-14T21:57:58+00:00","author":{"name":"PRO Antibiotic","image":"https:\/\/pbs.twimg.com\/profile_images\/446326416406491136\/CdfZ91EW_normal.jpeg","id_on_source":"Pro_antibiotic","tweeter_id":"2422915497","geo":{"lt":null,"ln":null},"followers":677},"tweet_id":"588098899790929921"},{"url":"https:\/\/twitter.com\/AntibioticLeeds\/status\/588211053701505025","license":"datasift","rt":["FarmUCI"],"citation_ids":[3908276],"posted_on":"2015-04-15T05:23:38+00:00","author":{"name":"Philip Howard","url":"http:\/\/nww.lhp.leedsth.nhs.uk\/antimicrobials","image":"https:\/\/pbs.twimg.com\/profile_images\/666506311757000704\/sqRxYL8O_normal.png","description":"Consultant Antimicrobial Pharmacist in Leeds. NHS Improvement AMR Project Lead. BSAC VP. All tweets are my own, and don't represent my employing organisations.","id_on_source":"AntibioticLeeds","tweeter_id":"216106495","geo":{"lt":54,"ln":-1.5,"country":"GB"},"followers":3174},"tweet_id":"588211053701505025"},{"url":"https:\/\/twitter.com\/MGilchrist123\/status\/588237872647561216","license":"datasift","rt":["FarmUCI"],"citation_ids":[3908276],"posted_on":"2015-04-15T07:10:12+00:00","author":{"name":"Mark Gilchrist","url":"http:\/\/www.e-opat.com","image":"https:\/\/pbs.twimg.com\/profile_images\/849703973934292995\/1vY7yreK_normal.jpg","description":"Consultant Pharmacist ID - Imperial. Co-chair BSAC OPAT. @rpharms AMR group. Passionate about learning & improving local, national, global AMS - Views my own","id_on_source":"MGilchrist123","tweeter_id":"2328608307","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":1098},"tweet_id":"588237872647561216"},{"url":"https:\/\/twitter.com\/mdialop1\/status\/588463055681548288","license":"datasift","rt":["FarmUCI"],"citation_ids":[3908276],"posted_on":"2015-04-15T22:05:00+00:00","author":{"name":"M\u00aa Dolores D\u00edaz","image":"https:\/\/pbs.twimg.com\/profile_images\/577061281481551872\/zPv8ngZE_normal.jpeg","id_on_source":"mdialop1","tweeter_id":"2824633418","geo":{"lt":null,"ln":null},"followers":34},"tweet_id":"588463055681548288"},{"url":"https:\/\/twitter.com\/jaime_latour\/status\/589444585765613568","license":"datasift","citation_ids":[3908276],"posted_on":"2015-04-18T15:05:15+00:00","author":{"name":"jaime latour perez","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000007496689\/1b74a25e9b4a3d5e14b05b0b7fb58847_normal.jpeg","id_on_source":"jaime_latour","tweeter_id":"1208843742","geo":{"lt":null,"ln":null},"followers":33},"tweet_id":"589444585765613568"},{"url":"https:\/\/twitter.com\/aky_synes\/status\/590437445264482304","license":"datasift","citation_ids":[3908276],"posted_on":"2015-04-21T08:50:31+00:00","author":{"name":"\u3042\u304f\u3086\u3093","image":"https:\/\/pbs.twimg.com\/profile_images\/634733339040026628\/5AgVbkGl_normal.jpg","description":"\u306d\u308b\u3053\u306f\u305d\u3060\u3064","id_on_source":"aky_synes","tweeter_id":"128477787","geo":{"lt":34.04011,"ln":131.570778,"country":"JP"},"followers":749},"tweet_id":"590437445264482304"},{"url":"https:\/\/twitter.com\/AnestesiaF\/status\/587194731798536195","license":"datasift","citation_ids":[3908276],"posted_on":"2015-04-12T10:05:08+00:00","author":{"name":"Anestesia-Fabumed","url":"http:\/\/www.fabumed.net\/","image":"https:\/\/pbs.twimg.com\/profile_images\/513933046764957696\/2ZhExTfY_normal.png","description":"Anestesia. Compartir, revisar y fomentar la realizaci\u00f3n de referencias de la Literatura M\u00e9dica Latinoamericana y a sus Autores.","id_on_source":"AnestesiaF","tweeter_id":"380571588","geo":{"lt":null,"ln":null},"followers":1638},"tweet_id":"587194731798536195"},{"url":"https:\/\/twitter.com\/FarmUCI\/status\/588098273753300993","license":"datasift","citation_ids":[3908276],"posted_on":"2015-04-14T21:55:29+00:00","author":{"name":"FarmUCI","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000644861340\/fc52105a3771c570a66c9c76d5b53c20_normal.jpeg","description":"Farmac\u00e9utic@s especialistas con inter\u00e9s en Farmacia Cl\u00ednica en Unidades de Cuidados Intensivos.","id_on_source":"FarmUCI","tweeter_id":"1943525227","geo":{"lt":null,"ln":null},"followers":1020},"tweet_id":"588098273753300993"},{"url":"https:\/\/twitter.com\/aky_synes\/status\/590437191664340992","license":"datasift","citation_ids":[3908276],"posted_on":"2015-04-21T08:49:30+00:00","author":{"name":"\u3042\u304f\u3086\u3093","image":"https:\/\/pbs.twimg.com\/profile_images\/634733339040026628\/5AgVbkGl_normal.jpg","description":"\u306d\u308b\u3053\u306f\u305d\u3060\u3064","id_on_source":"aky_synes","tweeter_id":"128477787","geo":{"lt":34.04011,"ln":131.570778,"country":"JP"},"followers":749},"tweet_id":"590437191664340992"},{"url":"https:\/\/twitter.com\/AnesthRea\/status\/590579653309521924","license":"datasift","citation_ids":[3908276],"posted_on":"2015-04-21T18:15:36+00:00","author":{"name":"Anesth & R\u00e9animation","url":"https:\/\/twitter.com\/Anesthrea","image":"https:\/\/pbs.twimg.com\/profile_images\/2209135195\/image_normal.jpg","description":"Actualit\u00e9s, bibliographie, discussions en anesth\u00e9sie et r\u00e9animation. #AnesthRea #Anesthesie #Reanimation #Intensivist #CriticalCare #Anesthesiology Marseille","id_on_source":"AnesthRea","tweeter_id":"576930807","geo":{"lt":46,"ln":2,"country":"FR"},"followers":947},"tweet_id":"590579653309521924"},{"url":"http:\/\/twitter.com\/kadsho\/statuses\/670484454863867905","license":"gnip","citation_ids":[3908276],"posted_on":"2015-11-28T06:08:45+00:00","author":{"name":"\u9580\u6751\u5c06\u592a Hosp Pharmacist","image":"https:\/\/pbs.twimg.com\/profile_images\/778806726757748737\/QcGpyRcy_normal.jpg","description":"PIC(JSHP)\/IDCP(JSC)\/CNP(JSNP)\/\u85ac\u7269\u7642\u6cd5\u5c02\u9580\u85ac\u5264\u5e2b(JSPHCS) #PharmaceuticalCare, #ClinicalPharmacy, #DI, #Pharmacoepidemiology, #EBM, #AntimicrobialStewardship #ASP","id_on_source":"kadsho","tweeter_id":"168488514","geo":{"lt":43.06417,"ln":141.34694,"country":"JP"},"followers":2132},"tweet_id":"670484454863867905"},{"url":"http:\/\/twitter.com\/jjcrazydiamond\/statuses\/670495524563234816","license":"gnip","rt":["kadsho"],"citation_ids":[3908276],"posted_on":"2015-11-28T06:52:44+00:00","author":{"name":"T.kimura","image":"https:\/\/pbs.twimg.com\/profile_images\/517326599541125120\/94LlLHIq_normal.jpeg","description":"\u795e\u6238\u306e\u75c5\u9662\u85ac\u5264\u5e2b\u3002 \u611f\u67d3\u75c7\u3001HIV\u3001\u96c6\u4e2d\u6cbb\u7642\u3001\u30dd\u30ea\u30d5\u30a1\u30fc\u30de\u30b7\u30fc\u3001\u962a\u795e\u3001\u91ce\u7403\u3001\u91ce\u7403","id_on_source":"jjcrazydiamond","tweeter_id":"538069163","geo":{"lt":34.6913,"ln":135.183,"country":"JP"},"followers":609},"tweet_id":"670495524563234816"},{"url":"http:\/\/twitter.com\/AnestesiaF\/statuses\/736151192745709568","license":"gnip","citation_ids":[3908276],"posted_on":"2016-05-27T11:04:56+00:00","author":{"name":"Anestesia-Fabumed","url":"http:\/\/www.fabumed.net\/","image":"https:\/\/pbs.twimg.com\/profile_images\/513933046764957696\/2ZhExTfY_normal.png","description":"Anestesia. Compartir, revisar y fomentar la realizaci\u00f3n de referencias de la Literatura M\u00e9dica Latinoamericana y a sus Autores.","id_on_source":"AnestesiaF","tweeter_id":"380571588","geo":{"lt":null,"ln":null},"followers":1638},"tweet_id":"736151192745709568"},{"url":"http:\/\/twitter.com\/AnestesiaF\/statuses\/736151523781054464","license":"gnip","citation_ids":[3908276],"posted_on":"2016-05-27T11:06:14+00:00","author":{"name":"Anestesia-Fabumed","url":"http:\/\/www.fabumed.net\/","image":"https:\/\/pbs.twimg.com\/profile_images\/513933046764957696\/2ZhExTfY_normal.png","description":"Anestesia. Compartir, revisar y fomentar la realizaci\u00f3n de referencias de la Literatura M\u00e9dica Latinoamericana y a sus Autores.","id_on_source":"AnestesiaF","tweeter_id":"380571588","geo":{"lt":null,"ln":null},"followers":1638},"tweet_id":"736151523781054464"},{"url":"http:\/\/twitter.com\/matthewjrowland\/statuses\/783207441664184320","license":"gnip","citation_ids":[3908276],"posted_on":"2016-10-04T07:29:40+00:00","author":{"name":"Matt Rowland","url":"https:\/\/www.ndcn.ox.ac.uk\/team\/matthew-rowland","image":"https:\/\/pbs.twimg.com\/profile_images\/910575272289820672\/eKVIxCq5_normal.jpg","description":"Clinical Lecturer in Intensive Care\/Anaesthetics, University of Oxford. Interests: ICU brain injury esp post-SAH\/Trauma\/Cardiac arrest. All my own views","id_on_source":"matthewjrowland","tweeter_id":"80118666","geo":{"lt":51.75222,"ln":-1.25596,"country":"GB"},"followers":749},"tweet_id":"783207441664184320"}]}}